BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36902104)

  • 21. Sickle red cells as danger signals on proinflammatory gene expression, leukotriene B4 and interleukin-1 beta production in peripheral blood mononuclear cell.
    Pitanga TN; Oliveira RR; Zanette DL; Guarda CC; Santiago RP; Santana SS; Nascimento VML; Lima JB; Carvalho GQ; Maffili VV; Carvalho MOS; Alcântara LCJ; Borges VM; Goncalves MS
    Cytokine; 2016 Jul; 83():75-84. PubMed ID: 27045344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mouse model for Sézary syndrome using xenotransplantation of Sézary cells into immunodeficient RAG2(-/-) γc(-/-) mice.
    van der Fits L; Rebel HG; Out-Luiting JJ; Pouw SM; Smit F; Vermeer KG; van Zijl L; Tensen CP; Weijer K; Vermeer MH
    Exp Dermatol; 2012 Sep; 21(9):706-9. PubMed ID: 22897578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
    Fierro MT; Comessatti A; Quaglino P; Ortoncelli M; Osella Abate S; Ponti R; Novelli M; Bernengo MG
    Dermatology; 2006; 213(4):284-92. PubMed ID: 17135733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis.
    Picozza M; Cristofoletti C; Bresin A; Fioretti M; Sambucci M; Scala E; Monopoli A; Cantonetti M; Pilla MA; Accetturi MP; Borsellino G; D'Atri S; Caprini E; Russo G; Narducci MG
    J Invest Dermatol; 2022 Nov; 142(11):3009-3019.e9. PubMed ID: 35533722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the role of IL18, IL-1β and NLRP3 inflammasome in reducing expression of FLG-2 protein in Psoriasis vulgaris skin lesions.
    Akhlaghi M; Karrabi M; Atabti H; Raoofi A; Mousavi Khaneghah A
    Biotech Histochem; 2022 May; 97(4):277-283. PubMed ID: 34313166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions.
    Doherty SD; Ni X; Doherty CB; Jones D; Zhao X; Owen LB; Duvic M
    Arch Dermatol Res; 2006 Dec; 298(7):353-6. PubMed ID: 17021762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
    Gao J; Ren S; Choonoo G; Chen G; Frleta D; Zhong J; Gupta N; Sharma P; Oyejide A; Atwal GS; Macdonald L; Murphy A; Kuhnert F
    Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37718909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lysed and non-lysed sickle red cells on the activation of NLRP3 inflammasome and LTB4 production by mononuclear cells.
    Pitanga TN; Santana SS; Zanette DL; Guarda CC; Santiago RP; Maffili VV; Lima JB; Carvalho GQ; Filho JR; Ferreira JRD; Aleluia MM; Nascimento VML; Carvalho MOS; Lyra IM; Borges VM; Oliveira RR; Goncalves MS
    Inflamm Res; 2021 Jul; 70(7):823-834. PubMed ID: 34196737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System.
    Roccuzzo G; Giordano S; Avallone G; Rubatto M; Canonico S; Funaro A; Ortolan E; Senetta R; Fava P; Fierro MT; Ribero S; Quaglino P
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sézary T-cell-activating factor induces functional interleukin 2 receptors on T-cells derived from patients with Sézary syndrome.
    Abrams JT; Ghosh SK; DeFreitas E
    Cancer Res; 1993 Nov; 53(22):5501-6. PubMed ID: 8221690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
    el-Azhary RA; Bouwhuis SA
    Int J Dermatol; 2005 Jan; 44(1):25-8. PubMed ID: 15663654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling.
    Mehdi SJ; Moerman-Herzog AM; Wong HK
    J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis.
    Sigurdsson V; de Vries IJ; Toonstra J; Bihari IC; Thepen T; Bruijnzeel-Koomen CA; van Vloten WA
    J Cutan Pathol; 2000 Oct; 27(9):436-40. PubMed ID: 11028813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome.
    van der Fits L; Out-Luiting JJ; van Leeuwen MA; Samsom JN; Willemze R; Tensen CP; Vermeer MH
    J Invest Dermatol; 2012 Feb; 132(2):440-7. PubMed ID: 21938013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance.
    Cristofoletti C; Bresin A; Picozza M; Picchio MC; Monzo F; Helmer Citterich M; Passarelli F; Frezzolini A; Scala E; Monopoli A; Cantonetti M; Benucci R; D'Atri S; Caprini E; Russo G; Narducci MG
    Leukemia; 2019 May; 33(5):1231-1242. PubMed ID: 30518812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defucosylated anti CC chemokine receptor 4 monoclonal antibody combined with immunomodulatory cytokines: a novel immunotherapy for aggressive/refractory Mycosis fungoides and Sezary syndrome.
    Yano H; Ishida T; Inagaki A; Ishii T; Ding J; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    Clin Cancer Res; 2007 Nov; 13(21):6494-500. PubMed ID: 17975162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome.
    Ortonne N; Le Gouvello S; Mansour H; Poillet C; Martin N; Delfau-Larue MH; Leroy K; Farcet JP; Bagot M; Bensussan A
    J Invest Dermatol; 2008 Feb; 128(2):465-72. PubMed ID: 17703174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.
    Kohnken R; Kodigepalli KM; Mishra A; Porcu P; Wu L
    Leuk Res; 2017 Jan; 52():58-66. PubMed ID: 27889686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
    Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
    J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.